Please use this identifier to cite or link to this item:
Title: Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
Authors: Naftalin C.M.
Verma R. 
Gurumurthy M. 
Hee K.H. 
Lu Q.
Yeo B.C.M. 
Tan K.H. 
Lin W. 
Yu B.
Seng K.Y. 
Lee L.S.-U. 
Paton N.I. 
Issue Date: 1-Dec-2018
Publisher: Nature Publishing Group
Citation: Naftalin C.M., Verma R., Gurumurthy M., Hee K.H., Lu Q., Yeo B.C.M., Tan K.H., Lin W., Yu B., Seng K.Y., Lee L.S.-U., Paton N.I. (2018-12-01). Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model. Scientific Reports 8 (1) : 13491. ScholarBank@NUS Repository.
Abstract: COX-2 inhibition may be of benefit in the treatment of tuberculosis (TB)爐hrough a number of pathways including efflux pump inhibition (increasing intracellular TB drug levels) and diverse effects on inflammation and the immune response. We investigated celecoxib (a COX-2 inhibitor) alone and with standard anti-tuberculosis drugs in the whole-blood bactericidal activity (WBA) model. Healthy volunteers took a single dose of celecoxib (400 mg), followed (after 1 week) by a single dose of either rifampicin (10 mg/kg) or pyrazinamide (25 mg/kg), followed (after 2 or 7 days respectively) by the same anti-tuberculosis drug with celecoxib. WBA was measured at intervals until 8 hours post-dose (by inoculating blood samples with Mycobacterium tuberculosis and estimating the change in bacterial colony forming units after 72 hours incubation). Celecoxib had no activity alone in the WBA assay (cumulative WBA over 8 hours post-dose: 0.03 � 0.01?logCFU, p = 1.00 versus zero). Celecoxib did not increase cumulative WBA of standard TB drugs (mean cumulative WBA ?0.10 � 0.13?logCFU versus ?0.10 � 0.12?logCFU for TB drugs alone versus TB drugs and celecoxib; mean difference ?0.01, 95% CI ?0.02 to 0.00; p = 0.16). The lack of benefit of celecoxib suggests that efflux pump inhibition or eicosanoid pathway-related responses are of limited importance in mycobacterial killing in the WBA assay. � 2018, The Author(s).
Source Title: Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-018-31590-4
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
s41598-018-31590-4.pdf1.37 MBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.